BioVie was invited to give 2 oral presentations about Alzheimer's disease. This brings attention to its work, but the report gives no new drug results or approval, so it does not change the company's outlook.
That gives BioVie a chance to discuss its work with researchers. The report includes no new drug test results or treatment approval. The talks concern drugs still being tested, so this news does not change the company's outlook.
Follow BioVie Inc. (BIVI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIVI